Annotation Detail

Information
Associated Genes
BCL2
Associated Variants
BCL2 UNDEREXPRESSION
Source Database
MMMP
Description
Phase III RCT. Setting: advanced disease. No overall survival advantage; significant increase of progression free survival and tumor response rate
MMMP State
downregulated by
MMMP Molecule
Bcl-2
MMMP Modifier
Oblimersen
MMMP Modifier Alias
Bcl-2 antisense oligo, G3139
MMMP Relationship
no relationship with
MMMP Drug
Dacarbazine
MMMP Drug Alias
DTIC
MMMP Model
6
MMMP Reference
Bedikian AY, J Clin Oncol 2006, 24:4738-45
MMMP DNA/mRNA/Protein
mRNA
Drugs
Drug NameSensitivitySupported
DacarbazineResitance or Non-Reponsetrue